Medx Health Corp (MDXHF) 0.1330 $MDXHF Taglich
Post# of 273322
Posted On: 09/24/2016 9:00:37 PM
Medx Health Corp (MDXHF) 0.1330 $MDXHF
Taglich Brothers Initiates Coverage on MDxHealth SA
Marketwire Canada - Mon May 09, 8:30AM CDT
NEW YORK, NY--(Marketwired - May 09, 2016) - Taglich Brothers, Inc. announces it initiated coverage of MDxHealth SA (EURONEXT BRUSSELS: MDXH)(OTC: MDXHF).
MedX Health Corp. Announces a 34% Revenue Increase in Its 2015 Year End Financial Results
Marketwired - Fri Apr 29, 5:17PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announced its results for the year ended December 31, 2015, which are also available on SEDAR (www.sedar.com).
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Closes 2015 With Positive Sales and Eliminates 10% Royalty Obligation
Marketwired - Thu Jan 07, 6:58AM CST
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX), a leading medical device company, announced it has completed a transaction that eliminates the 10% royalty obligation which was paid to the previous owner of its SIAscopy technology. To complete this transaction, MedX made a one-time payment of US$200,000 which was financed by a loan from a party related to its pharmacy channel partner.
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Issuance of Shares and Share Option Grant
Marketwired - Thu Dec 31, 5:27PM CST
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX) announces that, effective December 23, 2015, it has issued 3,253,437 common shares in settlement of a total of $406,565 of debt. This debt settlement was previously announced in a press release on November 27, 2015, which confirmed that at the Annual and Special Meeting of Shareholders held on November 23, 2015, shareholders approved the issuance of 2,550,000 common shares to insiders related to the settlement of $328,956 of indebtedness owing to certain insiders.
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Marketwired - Fri Nov 27, 5:45PM CST
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX) announced its results for the three and nine months ended September 30, 2015, which are also available on SEDAR (www.sedar.com).
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Proposed Debt Settlements
Marketwired - Wed Oct 28, 6:00PM CDT
MedX Health Corp. (TSX VENTURE: MDX), announces that it has entered into agreements to settle a total of $406,564.96 of debt owed to certain trade creditors and insider creditors, subject to all relevant consents and approvals. Under the Debt Settlement Agreements, a total of $77,609.25 of trade debt will be settled by issuance of 703,437 shares issued at prices between $0.10 and $0.25 per share and $328,955.71 of debt due to creditors who are insiders or are related to insiders will be settled by issuance of 2,550,000 shares issued at prices between $0.10 and $0.16 per share. Regulatory and other consents will include approval from the TSX Venture Exchange and, in relation to shares issuable to insiders and creditors related to insiders, approval of shareholders (excluding votes of shares owned by the relevant insiders).
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Selected by BodyCheck NL to Supply Its SIAscopy(TM) Skin Assessment Technology to Be Integrated in BodyCheck(TM) Testing Kits Internationally
Marketwired - Mon Oct 05, 1:20PM CDT
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX), a leading medical device company, announced it has completed an agreement to become the exclusive supplier of skin assessment technology to BodyCheck NL for the supply of its SIAscopy technology within all BodyCheck(TM) testing kits, currently in the Netherlands, and being marketed internationally.
MDX.VN: 0.195 (-0.015)
Global Dermatology Diagnostics Devices Market 2015-2019
M2 - Thu Sep 24, 10:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fk9wjj/global) has announced the addition of the "Global Dermatology Diagnostics Devices Market 2015-2019" report to their offering. Teledermatology is directed toward improving access to medical consultations while decreasing costs by eliminating travel for patients, physicians, and nurses. The adoption of telemedicine in recent years is rising because of better information technology in terms of affordability and performance. Telemedicine has become a standard in most of the clinical application areas, such as cardiology, orthopedics, and neurology. There is a growing interest in teledermatology because of the increasing need for dermatology services and the lack of specialists or dermatologists in many countries. For example, in the UK there has been an increase by 50% in dermatology referrals in the last decade. However, there are not many dermatologists available in the country to address the concerns. Teledermatology is one solution for the healthcare community to address the dermatology workforce challenge. According to the report, efforts to educate dermatologists and patients are expected to contribute to the growth of global dermatology diagnostic devices market. The initiatives taken by both government and private entities include regular education and training for physicians, conducting public awareness programs, and increase funding for scientific and epidemiological research. There are more than 2,000 recognized skin disorders. The increasing awareness and the need for improvement in diagnostic accuracy have created a relatively new responsibility and interest among practitioners in the field of dermatology. Accurate diagnosis and effective treatment depends on proficiency of general practitioners and dermatologists. Self-diagnosing and self-medicating by patients for dermatological conditions are major factors hindering market growth. Key Topics Covered - Executive summary - Scope of the report - Market research methodology - Introduction - Teledermatology and mobile apps - Market landscape - Market segmentation by application - Market segmentation by product - Geographical segmentation - Market drivers - Impact of drivers - Market challenges - Impact of drivers and challenges - Market trends - Vendor landscape - Major Vendor Analysis 2015 - Key vendor analysis Companies Mentioned - Caliber Imaging & Diagnostic - FotoFinder Systems - Heine Optotechnik - Longport - MedX Health Corp. - Mela Sciences - Michelson Diagnostics - SciBase AB - Verisante Technology - Welch Allyn For more information visit http://www.researchandmarkets.com/research/fk9wjj/global
MedX Health Corp. Announces a 67% Revenue Increase in Its Second Quarter 2015 Financial Results
Marketwired - Fri Aug 28, 4:04PM CDT
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX) announced its results for the three and six months ended June 30, 2015, which are also available on SEDAR (www.sedar.com).
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces $500,000 Debt Financing
Marketwired - Wed Jul 15, 3:20PM CDT
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX) announced that it has completed a $500,000 term loan with a party related to a Director of the Company.
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Pharmacy Pilot in the United Kingdom
Marketwired - Mon Jul 06, 4:35PM CDT
MedX Health Corp. ("MedX" or the "Company" (TSX VENTURE: MDX) gave an update on recent business developments today, announcing that its European pharmacy-focused channel partner commenced a mole-scanning pilot, using MedX's SIAscopy technology, in 25 Alphega Pharmacies in the United Kingdom.
MDX.VN: 0.195 (-0.015)
Taglich Brothers Initiates Coverage on MDxHealth SA
Marketwire Canada - Mon May 09, 8:30AM CDT
NEW YORK, NY--(Marketwired - May 09, 2016) - Taglich Brothers, Inc. announces it initiated coverage of MDxHealth SA (EURONEXT BRUSSELS: MDXH)(OTC: MDXHF).
MedX Health Corp. Announces a 34% Revenue Increase in Its 2015 Year End Financial Results
Marketwired - Fri Apr 29, 5:17PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announced its results for the year ended December 31, 2015, which are also available on SEDAR (www.sedar.com). MDX.VN: 0.195 (-0.015)
MedX Health Corp. Closes 2015 With Positive Sales and Eliminates 10% Royalty Obligation
Marketwired - Thu Jan 07, 6:58AM CST
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX), a leading medical device company, announced it has completed a transaction that eliminates the 10% royalty obligation which was paid to the previous owner of its SIAscopy technology. To complete this transaction, MedX made a one-time payment of US$200,000 which was financed by a loan from a party related to its pharmacy channel partner. MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Issuance of Shares and Share Option Grant
Marketwired - Thu Dec 31, 5:27PM CST
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announces that, effective December 23, 2015, it has issued 3,253,437 common shares in settlement of a total of $406,565 of debt. This debt settlement was previously announced in a press release on November 27, 2015, which confirmed that at the Annual and Special Meeting of Shareholders held on November 23, 2015, shareholders approved the issuance of 2,550,000 common shares to insiders related to the settlement of $328,956 of indebtedness owing to certain insiders. MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Marketwired - Fri Nov 27, 5:45PM CST
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announced its results for the three and nine months ended September 30, 2015, which are also available on SEDAR (www.sedar.com). MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Proposed Debt Settlements
Marketwired - Wed Oct 28, 6:00PM CDT
MedX Health Corp. (TSX VENTURE: MDX), announces that it has entered into agreements to settle a total of $406,564.96 of debt owed to certain trade creditors and insider creditors, subject to all relevant consents and approvals. Under the Debt Settlement Agreements, a total of $77,609.25 of trade debt will be settled by issuance of 703,437 shares issued at prices between $0.10 and $0.25 per share and $328,955.71 of debt due to creditors who are insiders or are related to insiders will be settled by issuance of 2,550,000 shares issued at prices between $0.10 and $0.16 per share. Regulatory and other consents will include approval from the TSX Venture Exchange and, in relation to shares issuable to insiders and creditors related to insiders, approval of shareholders (excluding votes of shares owned by the relevant insiders).
MDX.VN: 0.195 (-0.015)
MedX Health Corp. Selected by BodyCheck NL to Supply Its SIAscopy(TM) Skin Assessment Technology to Be Integrated in BodyCheck(TM) Testing Kits Internationally
Marketwired - Mon Oct 05, 1:20PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX), a leading medical device company, announced it has completed an agreement to become the exclusive supplier of skin assessment technology to BodyCheck NL for the supply of its SIAscopy technology within all BodyCheck(TM) testing kits, currently in the Netherlands, and being marketed internationally. MDX.VN: 0.195 (-0.015)
Global Dermatology Diagnostics Devices Market 2015-2019
M2 - Thu Sep 24, 10:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fk9wjj/global) has announced the addition of the "Global Dermatology Diagnostics Devices Market 2015-2019" report to their offering. Teledermatology is directed toward improving access to medical consultations while decreasing costs by eliminating travel for patients, physicians, and nurses. The adoption of telemedicine in recent years is rising because of better information technology in terms of affordability and performance. Telemedicine has become a standard in most of the clinical application areas, such as cardiology, orthopedics, and neurology. There is a growing interest in teledermatology because of the increasing need for dermatology services and the lack of specialists or dermatologists in many countries. For example, in the UK there has been an increase by 50% in dermatology referrals in the last decade. However, there are not many dermatologists available in the country to address the concerns. Teledermatology is one solution for the healthcare community to address the dermatology workforce challenge. According to the report, efforts to educate dermatologists and patients are expected to contribute to the growth of global dermatology diagnostic devices market. The initiatives taken by both government and private entities include regular education and training for physicians, conducting public awareness programs, and increase funding for scientific and epidemiological research. There are more than 2,000 recognized skin disorders. The increasing awareness and the need for improvement in diagnostic accuracy have created a relatively new responsibility and interest among practitioners in the field of dermatology. Accurate diagnosis and effective treatment depends on proficiency of general practitioners and dermatologists. Self-diagnosing and self-medicating by patients for dermatological conditions are major factors hindering market growth. Key Topics Covered - Executive summary - Scope of the report - Market research methodology - Introduction - Teledermatology and mobile apps - Market landscape - Market segmentation by application - Market segmentation by product - Geographical segmentation - Market drivers - Impact of drivers - Market challenges - Impact of drivers and challenges - Market trends - Vendor landscape - Major Vendor Analysis 2015 - Key vendor analysis Companies Mentioned - Caliber Imaging & Diagnostic - FotoFinder Systems - Heine Optotechnik - Longport - MedX Health Corp. - Mela Sciences - Michelson Diagnostics - SciBase AB - Verisante Technology - Welch Allyn For more information visit http://www.researchandmarkets.com/research/fk9wjj/global
MedX Health Corp. Announces a 67% Revenue Increase in Its Second Quarter 2015 Financial Results
Marketwired - Fri Aug 28, 4:04PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announced its results for the three and six months ended June 30, 2015, which are also available on SEDAR (www.sedar.com). MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces $500,000 Debt Financing
Marketwired - Wed Jul 15, 3:20PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) announced that it has completed a $500,000 term loan with a party related to a Director of the Company. MDX.VN: 0.195 (-0.015)
MedX Health Corp. Announces Pharmacy Pilot in the United Kingdom
Marketwired - Mon Jul 06, 4:35PM CDT
MedX Health Corp. ("MedX" or the "Company"
(TSX VENTURE: MDX) gave an update on recent business developments today, announcing that its European pharmacy-focused channel partner commenced a mole-scanning pilot, using MedX's SIAscopy technology, in 25 Alphega Pharmacies in the United Kingdom. MDX.VN: 0.195 (-0.015)
(0)
(0)